cinclus pharma header stockholm

Investor relations

Cinclus Pharma

Investors

Cinclus Pharma is a Swedish clinical stage pharma company developing small molecules for the treatment of gastric acid related diseases. Our lead candidate linaprazan glurate is being developed for treatment of severe gastroesophageal reflux disease (GERD).

Latest financial reports

See all

Financial calendar

See all

Latest pressreleases


See allSubscribe

Contact


Cinclus Henrik

Henrik Vikström

Head of IR

E-mail: Send e-mail

E-mail: Send e-mail